<DOC>
	<DOC>NCT00756652</DOC>
	<brief_summary>In November 2006, U.S. Food and Drug Administration (FDA) approved Mentor's MemoryGel silicone gel-filled breast implants for use in women who are undergoing primary or revisional breast augmentation and primary or revisional breast reconstruction surgery. This postapproval study is intended to satisfy one element of FDA's postapproval monitoring requirements. In January 2015, the FDA approved a protocol amendment that limits the scope of data collection for the study to the collection of only secondary procedure/reoperation data for MemoryGel participants.</brief_summary>
	<brief_title>Mentor MemoryGel Post-Approval Study</brief_title>
	<detailed_description />
	<criteria>1. Female, age 18 years or older (22 or older for breast augmentation patients) 2. U.S. resident 1. If a saline participant, current or past, unilateral or bilateral, silicone breast implants 2. Active infection anywhere in her body 3. Existing breast cancer or precancer of the breast without adequate treatment for those conditions 4. Currently pregnant or nursing</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>